M
Marguerite Ennis
Researcher at University of Toronto
Publications - 84
Citations - 6366
Marguerite Ennis is an academic researcher from University of Toronto. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 34, co-authored 75 publications receiving 5838 citations. Previous affiliations of Marguerite Ennis include University Health Network & Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
Saroj Niraula,Ryan J.O. Dowling,Marguerite Ennis,Martin C. Chang,Martin C. Chang,Susan J. Done,Susan J. Done,Nicky Hood,Jaime Escallon,Jaime Escallon,Wey Liang Leong,Wey Liang Leong,David R. McCready,David R. McCready,Michael Reedijk,Michael Reedijk,Vuk Stambolic,Pamela J. Goodwin,Pamela J. Goodwin +18 more
TL;DR: Short-term preoperative metformin was well tolerated and resulted in clinical and cellular changes consistent with beneficial anti-cancer effects; evaluation of the clinical relevance of these findings in adequately powered clinical trials using clinical endpoints such as survival is needed.
Journal ArticleDOI
Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
Pamela J. Goodwin,Kathleen I. Pritchard,Kathleen I. Pritchard,Marguerite Ennis,Mark Clemons,Margaret Graham,I. George Fantus,I. George Fantus +7 more
TL;DR: Metformin significantly lowers insulin levels, and it improves insulin resistance in nondiabetic women with breast cancer.
Journal ArticleDOI
Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations
Pamela J. Goodwin,Marguerite Ennis,Kathleen I. Pritchard,Maureen E. Trudeau,Jarley Koo,Sara Kristina Taylor,Nicky Hood +6 more
TL;DR: Baseline insulin- and obesity-related variables exert different patterns of prognostic associations over time in early BC, with evidence that associations of baseline insulin- related variables with distant recurrence and death were not constant over time.
Journal ArticleDOI
Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis
TL;DR: It is concluded that there is no evidence showing that the association of obesity with breast cancer outcome differs by hormone receptor or menopausal status, which has implications for studies of weight loss interventions in the adjuvant BC setting.
Journal ArticleDOI
Quality of Life in a Randomized Trial of Group Psychosocial Support in Metastatic Breast Cancer: Overall Effects of the Intervention and an Exploration of Missing Data
Louise Bordeleau,John Paul Szalai,Marguerite Ennis,Molyn Leszcz,Michael Speca,Rami Sela,Richard Doll,Harvey M. Chochinov,Margaret Navarro,Andrew Arnold,Kathleen I. Pritchard,Andrea Bezjak,Hilary A. Llewellyn-Thomas,Carol Sawka,Pamela J. Goodwin +14 more
TL;DR: Supportive-expressive group therapy in patients with metastatic breast cancer does not appear to influence HrQOL, as measured by the EORTC QLQ-C30, and primary analysis of all subscales failed to show a significant influence of the intervention.